Funding Opportunities

“High” or “Medium” Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers (R21) Standard AIDS Dates apply

PA-16-425

NIH

“High” or “Medium” Priority AIDS Research  on Non-AIDS-defining or AIDS-defining Cancers (R21)

Funding Opportunity Purpose

Standard AIDS dates apply by 5:00 PM local time of applicant organization.

Expires: Spetember 8, 2019

The purpose of this funding opportunity announcement (FOA) is to continue advancing our understanding of the risks, development, progression, diagnosis, and treatment of malignancies observed in individuals with an underlying human immunodeficiency (HIV) infection or acquired immunodeficiency syndrome (AIDS), particularly the non-AIDS defining malignancies which are now a leading cause of death in HIV-infected individuals.  

This FOA encourages high or medium priority AIDS research in areas such as the study of the etiologic factors, cofactors, immunopathogenesis, diagnosis, and consequences of both non-AIDS defining and AIDS-defining malignancies in populations with an underlying HIV infection. 

This FOA encourages research efforts that will (i) identify specific contributions resulting from HIV infection and its potential interaction with other pathogens for the development and pathogenesis of these cancers and (ii) provide information on the clinical outcomes of such cancers in the HIV-infected population. Ultimately, such efforts could inform screening approaches and therapies targeted to the HIV-infected population.   

Learn More